Healshape

Healshape, founded in 2020, is a promising player in the Biotechnology and 3D Printing industries, headquartered in France. The company positions itself as "A regenerative medicine company" aiming to revolutionize reconstructive surgery for women post-mastectomy through innovative 3D bioprinting technology.

In its short operational span, Healshape has successfully garnered investor confidence, as evidenced by a substantial €6.00M Seed Round investment completed on 28 June 2022. The funding round attracted notable investors, including Bpifrance, Demeter, Angels Santé, Crédit Agricole, Go Capital, and Win Equity.

As a pioneering firm in the high-potential field of regenerative medicine, Healshape is uniquely positioned to leverage its technological advancements for significant social impact, addressing an unmet need in restorative healthcare. This strategic vision, combined with solid financial backing, makes Healshape an attractive opportunity for investors seeking innovation-led growth within the healthcare sector.